Skip to content

Evaluation of intestinal vascularisation for predicting inflammatory activity by innovative ultrasound methods for therapy monitoring of patients with chronic inflammatory bowel disease.

Evaluation of intestinal vascularisation for predicting inflammatory activity by innovative ultrasound methods for therapy monitoring of patients with chronic inflammatory bowel disease. - iUS-CIBD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036574
Enrollment
54
Registered
2025-05-28
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K51.9 K50.9

Interventions

Group 1: As part of the study, targeted ultrasound examinations of the inflamed bowel segments are conducted, along with a clinical assessment of the current inflammatory activity. The primary examin

Sponsors

Universitätsklinikum Halle (Saale), Anstalt öffentlichen Rechts und Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Chronic inflammatory bowel disease with clinical suspicion of an acute flare-up - Bowel wall thickness in the affected section > 3 mm - Written informed consent

Exclusion criteria

Exclusion criteria: - Infectious enteritis - Pregnancy / breastfeeding - Non-essential medication therapy for the acute flare-up - Non-consenting patients - Inadequate examination conditions

Design outcomes

Primary

MeasureTime frame
The intestinal vascularization as a predictor for activity of inflammation shows a significant reduction after start of therapy.

Secondary

MeasureTime frame
1. After start of therapy a decrease of intestinal stiffness measured by strain and shear wave elastography is measured 2. Thickness of the intestinal wall decreases after a positive response to therapy. 3. Sonographic methods correlate well with clinical, laboratory and endoscopic markers of activity

Countries

Germany

Contacts

Public ContactValentin Blank

Universitätsklinikum Halle (Saale)

valentin.blank@uk-halle.de0345-5572733

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026